VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PTCT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PTCTPTC Therapeutics, Inc.
$85.44$7.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPTCTQuarterly Financials

PTC Therapeutics, Inc. (PTCT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

PTC Therapeutics, Inc. (PTCT) quarterly income statement — complete revenue, gross profit & net income history

PTCT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue272.55M164.68M211.01M178.88M1.18B213.17M196.79M186.7M210.12M307.06M196.58M213.81M220.38M167.41M217.13M165.53M148.74M165.23M138.74M116.68M
Revenue Growth %-76.83%-22.75%7.23%-4.19%459.73%-30.58%0.11%-12.68%-4.66%83.41%-9.46%29.17%48.17%1.32%56.5%41.87%26.11%39.01%17.18%55.07%
Cost of Goods Sold39.61M16.3M115.94M11.42M12.86M16.28M10.85M15.53M14.74M106.29M9.49M12.73M14.14M10.89M14.01M9.64M10.13M9.33M6.54M7.36M
COGS % of Revenue14.53%9.9%54.95%6.38%1.09%7.64%5.51%8.32%7.02%34.62%4.83%5.95%6.42%6.51%6.45%5.82%6.81%5.64%4.71%6.31%
Gross Profit232.94M148.38M95.07M167.46M1.16B196.89M185.94M171.18M195.38M200.76M187.08M201.08M206.24M156.52M203.12M155.89M138.6M155.9M132.2M109.32M
Gross Margin %85.47%90.1%45.05%93.62%98.91%92.36%94.49%91.68%92.98%65.38%95.17%94.05%93.58%93.49%93.55%94.18%93.19%94.36%95.29%93.69%
Gross Profit Growth %-79.97%-24.64%-48.87%-2.17%495.38%-1.93%-0.61%-14.87%-5.27%28.27%-7.89%28.99%48.8%0.4%53.64%42.6%27.35%36.78%16.24%56.31%
Operating Expenses187.06M230M92.05M202.41M193.01M359.28M240.45M211.4M240.83M197.64M305.25M410.62M323.85M356.86M276.6M248.25M225.12M240.63M225.28M207.81M
OpEx % of Revenue68.63%139.67%43.63%113.16%16.41%168.54%122.19%113.22%114.62%64.37%155.28%192.05%146.95%213.16%127.39%149.98%151.36%145.64%162.37%178.11%
Selling, General & Admin86.18M100.47M84.05M85.26M80.96M84.68M73.46M69.5M73.27M76.29M80.89M88.45M86.91M92.72M80.12M79.89M73.27M86.55M69.25M68.88M
SG&A % of Revenue31.62%61.01%39.83%47.67%6.88%39.73%37.33%37.22%34.87%24.85%41.15%41.37%39.44%55.38%36.9%48.27%49.26%52.38%49.91%59.03%
Research & Development100.87M133.13M100.16M112.99M108.97M124.77M161.41M132.17M116.13M121.35M164.21M185.87M195.12M188.69M165.46M157.26M140.08M149.84M130.84M125.48M
R&D % of Revenue37.01%80.84%47.47%63.17%9.27%58.53%82.02%70.79%55.27%39.52%83.54%86.94%88.54%112.71%76.21%95.01%94.18%90.69%94.31%107.55%
Other Operating Expenses0-1000K-1000K1000K1000K1000K1000K1000K1000K01000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income45.89M-81.62M3.02M-34.96M970.23M-162.39M-54.51M-40.22M-45.45M3.12M-118.16M-209.54M-117.61M-200.34M-73.49M-92.36M-86.52M-84.73M-93.08M-98.49M
Operating Margin %16.84%-49.57%1.43%-19.54%82.5%-76.18%-27.7%-21.54%-21.63%1.02%-60.11%-98.01%-53.37%-119.67%-33.85%-55.8%-58.17%-51.28%-67.09%-84.42%
Operating Income Growth %-95.27%49.74%105.53%13.08%2234.57%-5304.78%53.87%80.81%61.35%101.56%-60.8%-126.87%-35.94%-136.45%21.05%6.22%11.85%12.08%-68.83%47.41%
EBITDA61.3M-68.72M14.13M-27.37M977.45M-155.63M-48.02M-33.2M9.94M83.83M-53.63M-158.54M-74.79M-161.48M-35.8M-63.18M-60.21M-65.92M-76.33M-83.51M
EBITDA Margin %22.49%-41.73%6.69%-15.3%83.11%-73%-24.4%-17.78%4.73%27.3%-27.28%-74.15%-33.94%-96.45%-16.49%-38.17%-40.48%-39.9%-55.01%-71.57%
EBITDA Growth %-93.73%55.84%129.41%17.55%9731.48%-285.65%10.45%79.06%113.29%151.91%-49.8%-150.92%-24.22%-144.96%53.1%24.34%28.8%21.5%-75.51%52.84%
D&A (Non-Cash Add-back)15.41M12.9M11.11M7.58M7.22M6.76M6.49M7.02M55.4M80.7M64.54M51.01M42.83M38.87M37.69M29.18M26.31M18.81M16.75M14.99M
EBIT45.89M-83.89M9.52M-40.69M963.92M-53.64M-56.38M-42.24M-43.86M-112.78M-138.43M-208.06M-107.66M-165.19M-106.33M-126.72M-98.38M-116.11M-111.86M-95.32M
Net Interest Income49.03M-55.19M-32.59M-30.36M-34.09M-41.06M-41.61M-43.49M-40.83M-44.27M-28.16M-29.41M-27.33M-24.5M-20.88M-21.98M-23.51M-22.5M-21.8M-22.56M
Interest Income00000000000000000000
Interest Expense-49.03M55.19M32.59M30.36M34.09M41.06M41.61M43.49M40.83M44.27M28.16M29.41M27.33M24.5M20.88M21.98M23.51M22.5M21.8M22.56M
Other Income/Expense-48.35M-57.46M-26.09M-36.09M-40.4M67.69M-43.48M-45.52M-39.24M-160.17M-48.43M-27.94M-17.38M10.65M-53.72M-56.33M-35.37M-53.88M-40.58M-19.39M
Pretax Income-2.46M-139.08M-23.07M-71.05M929.83M-94.7M-97.99M-85.73M-84.7M-157.05M-166.59M-237.48M-134.99M-189.69M-127.21M-148.69M-121.89M-138.61M-133.66M-117.88M
Pretax Margin %-0.9%-84.46%-10.94%-39.72%79.06%-44.42%-49.8%-45.92%-40.31%-51.15%-84.75%-111.07%-61.25%-113.31%-58.59%-89.83%-81.95%-83.89%-96.34%-101.03%
Income Tax347K-4.12M-38.97M-6.2M63.27M-28.81M8.66M13.45M6.88M-1.26M-33.62M-38.6M3.97M-18.8M-17.89M3.39M4.83M4.66M-36K488K
Effective Tax Rate %-14.09%2.96%168.89%8.73%6.8%30.43%-8.84%-15.68%-8.12%0.8%20.18%16.25%-2.94%9.91%14.07%-2.28%-3.97%-3.36%0.03%-0.41%
Net Income-2.81M-134.97M15.9M-64.85M866.56M-65.89M-106.65M-99.18M-91.58M-155.79M-132.97M-198.88M-138.96M-170.89M-109.31M-152.09M-126.73M-143.26M-133.62M-118.37M
Net Margin %-1.03%-81.96%7.53%-36.25%73.68%-30.91%-54.2%-53.12%-43.58%-50.74%-67.64%-93.02%-63.05%-102.08%-50.35%-91.88%-85.2%-86.71%-96.31%-101.45%
Net Income Growth %-100.32%-104.85%114.9%34.61%1046.28%57.71%19.79%50.13%34.1%8.83%-21.64%-30.77%-9.65%-19.28%18.19%-28.48%1.49%-92.68%-91.74%34.76%
Net Income (Continuing)-2.81M-134.97M15.9M-64.85M866.56M-65.89M-106.65M-99.18M-91.58M-155.79M-132.97M-198.88M-138.96M-170.89M-109.31M-152.09M-126.73M-143.26M-133.62M-118.37M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.03-1.670.20-0.8310.04-0.85-1.39-1.29-1.20-2.06-1.76-2.66-1.88-2.35-1.53-2.13-1.78-2.03-1.89-1.68
EPS Growth %-100.34%-96.47%114.39%35.66%936.67%58.74%21.02%51.5%36.17%12.34%-15.03%-24.88%-5.62%-15.76%19.05%-26.79%2.73%-82.88%-83.5%39.57%
EPS (Basic)-0.03-1.670.20-0.8311.09-0.85-1.39-1.29-1.20-2.06-1.76-2.66-1.88-2.35-1.53-2.13-1.78-2.03-1.89-1.68
Diluted Shares Outstanding82.52M80.69M87.12M78.15M86.39M77.2M76.93M76.73M76.5M75.51M75.38M74.73M73.73M72.66M71.65M71.37M71.22M70.67M70.59M70.41M
Basic Shares Outstanding82.52M80.69M81.5M78.15M78.12M77.2M76.93M76.73M76.5M75.51M75.38M74.73M73.73M72.66M71.45M71.37M71.22M70.67M70.59M70.41M
Dividend Payout Ratio--------------------